How Artificial Intelligence Is Reshaping Clinical Trials — Opportunities and Risks

With advancements in digital technology and AI (artificial intelligence), the clinical research landscape is undergoing a paradigm shift. Through predictive analytics, real-time monitoring, adaptive trial designs, and improved data interpretation, AI can transform clinical trials by making them more precise, faster, and scalable. In this article, we discuss the various applications of AI across the clinical research ecosystem and some key opportunities that could enable us to realize a more efficient and personalized future for medicine. On the other hand, the use of AI is associated with its challenges, such as data privacy issues, algorithmic bias, regulatory complexities, and ethical dilemmas that need to be tackled to ensure responsible and equitable utilization. As AI technologies continue to advance, their incorporation in clinical research must follow a synergistic, well-coordinated, transparent, and ethically driven pathway toward their full potential.

Clinical research is at the core of evidence-based medicine and is the wellspring of innovation in the prevention, diagnosis, and treatment of disease, as well as health policy. Historically, clinical research methodology has been defined by high levels of regulatory screening, well-defined trial protocols, and dependence on clinical data sets in the hundreds of thousands. Despite its rigor, traditional clinical research faces persistent bottlenecks, particularly in patient recruitment (slow and expensive), population and genetic homogeneity, fragmented data, and the long duration of trials. These obstacles can outright halt the development and delivery of potentially life-saving therapies.

Artificial Intelligence (AI) has become a powerful tool with the potential to revolutionize the clinical research ecosystem. AI encompasses various computational technologies—including machine learning, deep learning, NLP, and computer vision—that allow machines to accomplish tasks normally requiring human intelligence. These technologies have potential use cases in all stages of clinical research, including early-stage protocol design, hypothesis generation, real-time patient monitoring, and post-trial data analysis.

For instance, machine learning algorithms can process large volumes of data, identify trends, and make accurate predictions regarding clinical outcomes. Natural language processing tools help to extract relevant clinical information from unstructured text, including physician notes, pathology reports, or published literature. AI can also help identify eligible participants by screening electronic health records (EHRs), which can increase the efficiency of recruitment and improve trial diversity. In adaptive trials, artificial intelligence can be utilized to dynamically modify protocol parameters using early data to shorten timelines and increase participant safety.

In addition, the integration of AI in digital health technologies, including but not limited to wearable devices, smartphone applications, and remote sensors, has transformed the way patient data is collected and analyzed. These technologies allow for real-time, continuous monitoring of patient vitals, adherence, and outcomes, yielding richer datasets for deeper insights and more data-driven decision-making.

However, while the potential for AI in clinical research is transformative, there are major barriers to wide adoption that have yet to be overcome. Top concerns include data privacy, algorithmic transparency, regulatory compliance, and developing ethical approaches to issues of bias and equity. Data quality issues or biased training datasets can result in inaccurate predictions and deepen existing health disparities. Moreover, the "black box" nature of some forms of AI may limit their explainability, undermining trust and acceptance by clinicians and regulators.

Given the changing nature of the field, it is becoming more and more apparent that a multidisciplinary approach involving data scientists, clinical researchers, ethicists, policymakers, and patients is needed to ensure the safe, effective, and equitable use of clinical AI in the research process.

Artificial intelligence is no longer a futuristic concept in clinical research—it is a present-day force reshaping how trials are designed, conducted, and analyzed. Its transformative power, however, must be matched with responsible implementation. If deployed ethically and collaboratively, AI holds the promise of making clinical research faster, safer, and more patient-centric.

References:

1. González, José M., et al. “Artificial Intelligence Applied to Clinical Trials: Opportunities and Challenges.” Health and Technology 13, no. 1 (2023): 1–10. https://link.springer.com/article/10.1007/s12553-023-00738-2.

2. Coherent Solutions. “Machine Learning and AI in Clinical Trials: Use Cases.” April 2025. https://www.coherentsolutions.com/insights/role-of-ml-and-ai-in-clinical-trials-design-use-cases-benefits.

3. Linical. “How Artificial Intelligence (AI) Is Revolutionizing Clinical Trials.” September 2024. https://www.linical.com/articles-research/how-ai-is-revolutionizing-clinical-trials.

4. Journal of Clinical and Translational Science. “Embracing Generative Artificial Intelligence in Clinical Research and Beyond.” ScienceDirect 9, no. 2 (2025): 123–130. https://www.sciencedirect.com/science/article/pii/S2772963X25000109.

5. Applied Clinical Trials. “How AI Lowers the Real-World Barriers to Trial Participation.” Accessed June 5, 2025. https://www.appliedclinicaltrialsonline.com/view/ai-lowers-real-world-barriers-trial-participation.

6. Journal of Clinical Ethics. “Ethical and Regulatory Challenges in Machine Learning-Based Clinical Research.” ScienceDirect 36, no. 1 (2025): 45–52. https://www.sciencedirect.com/science/article/pii/S2772485925000286.

7. National Center for Biotechnology Information. “Artificial Intelligence Applied to Clinical Trials: Opportunities and Challenges.” PubMed (2023). https://pubmed.ncbi.nlm.nih.gov/36923325/.

8. BMC Medical Ethics. “Privacy and Artificial Intelligence: Challenges for Protecting Health Data.” BMC Medical Ethics 22, no. 1 (2021): 1–9. https://bmcmedethics.biomedcentral.com/articles/10.1186/s12910-021-00687-3.

9. Lindus Health. “AI Study Design in Clinical Trials: Revolutionizing Research Methodologies.” Accessed June 5, 2025. https://www.lindushealth.com/blog/ai-study-design-in-clinical-trials-revolutionizing-research-methodologies.

10. Medrio. “AI in Clinical Trials: How It Will Shape the Future.” Accessed June 5, 2025. https://medrio.com/blog/ai-in-clinical-trials/.

By Veena Reddappa, MSc Clinical Research

_MSM/SE